T-ALL accounts for 15% of pediatric and 25% of adult ALL cases, very frequently bearing somatic gain-of-function gene mutations in Notch1, as well as overexpression of Notch3 [1–3]. The gene discussed is NOTCH1; the disease is acute lymphoblastic leukemia.